Enlicitide, which could be the first oral medication that blocks the protein PCSK9, helped cut cholesterol levels in a pair ...

Antibody-drug conjugates have emerged as a promising cancer treatment ... compared to monotherapies. Patients in this study also exhibited durable responses, with some experiencing long-term remission ...